Apollomics net loss for six months ended June 30, 2026 narrows 30% to USD 8.77 million

• Apollomics’ net loss narrowed 30% year over year to $8.77 million for the six months ended June 30, 2026.
• Revenue fell to nil from $8.5 million a year earlier.
• Cash totaled $1.01 million at June 30, 2026; management identified substantial doubt about the company’s ability to continue as a going concern.
• A $2.3 million impairment fully reserved the LaunXP receivable following nonpayment; the licensing agreement terminated effective June 11, 2026.
• The August 14, 2026 private placement generated approximately $8 million in cash proceeds and extinguished the $2 million convertible promissory note.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apollomics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-451861), on November 06, 2026, and is solely responsible for the information contained therein.